FDA Approves Pritelivir for Refractory HSV in Immunocompromised Adults
FDA Approves Pritelivir for Refractory HSV in Immunocompromised Adults Contagion Live
Regulatory Approvals
Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia
Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and…
Israeli Pharma Giant Teva Wins FDA Approval for Monthly Schizophrenia Injection Weltruza
Israeli Pharma Giant Teva Wins FDA Approval for Monthly Schizophrenia Injection Weltruza Haaretz
FDA approves Parkinson’s drug based on University of Virgini…
FDA approves Parkinson’s drug based on University of Virgini... FauquierNow
FDA Approves Treatment Combination for Maintenance of Patients With Advanced HER2-Positive Breast Cancer
FDA Approves Treatment Combination for Maintenance of Patients With Advanced HER2-Positive Breast Cancer Breast Cancer Research Foundation | BCRF